Emerging Players Increasing Presence In The Americas

BMI View: We believe that a growing number of domestic drugmakers in Latin America will step up efforts to increase market presence in both developed and neighbouring emerging markets, due to the potential for higher returns. This view is supported by the strong growth in international sales reported by Mexican over-the-counter (OTC) and generic drugmaker Genomma Lab in its Q310 financial report.

To read the full article, please choose one of the following options: